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O R IG IN A L  PAPER
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M. A. Latijnhouwers * E. M. G. J. de Jong
Epicutaneous application of leukotriene B4  induces patterns 
of tenascin and a heparan sulfate proteoglycan epitope that are typical 
for psoriatic lesions
R ece ived :  .13 J u n e  1996
Abstract Application of leukotriene B4 (LTB4) to nor­
mal human skin induces changes similar to those found 
in psoriatic skin, and it has proved to be a useful model 
for studying the pathogenesis and treatment of psoria­
sis. We studied the expression patterns of molecules 
that have recently been shown to be altered in lesional 
psoriatic skin, including the extracellular matrix pro­
tein tenascin (TN) and the basement membrane and 
cell surface-associated heparan sulfate proteoglycans 
(HSPGs). During 72-h the expression of these markers 
was studied immunohistochemically and the expres­
sion of TN was correlated with epidermal proliferation 
and influx of inflammatory cells. Following the peak 
influx of polymorphonuclear leukocytes, a marked in­
crease in TN expression was noted in the papillary der­
mis 72 h after LTB4 application. The expression pat­
terns of basal membrane-associated epitopes of HSPG  
remained unaltered, whereas the expression of cell sur­
face-associated IISPG disappeared 72 h after LTB4 ap­
plication. A significant correlation was found between 
dermal TN expression and epidermal hyperprolifera­
tion, and between TN expression and the presence of 
dermal T cells. These findings indicate that the model 
of LTB4-induced acute cutaneous inflammation dis­
plays many characteristics of early psoriatic lesions 
and could serve as a model to study some of the cell bi­
ological changes in this disease.
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Epiculaneoiis application of the potent chemoattractant 
leukotriene B4 (LTB4) results in a reproducible cutaneous 
inflammatory response, initially dominated by an accu­
mulation of polymorphonuclear leukocytes (PMN) with a 
maximum at 24 h, and followed by a dermal T-cell infil­
trated which is most pronounced after 72 h, Epidermal hy­
perproliferation occurs, reaching a maximum after 72-96 h. 
These phenomena are dose dependent [1, 2]. Although 
LTB4 is not likely to be the only or prinuirly pathogenetic 
event in psoriasis [3], the morphologic changes in the skin 
using the LTB4-mod.el are a useful means of investigating 
acute inflammation in vivo and partially mimic the hall­
marks of psoriatic skin lesions,
The extracellular matrix (ECM) plays an important 
role in cell growth, differentiation and migration. It pro­
vides firmness, elasticity, and resilience to tissues. The 
ECM is not inert but interacts with keratinocytes, inflam­
matory cells, cytokines and growth factors. Recently it 
has been shown that some ECM molecules are altered in 
lesional skin of psoriatic patients [4, 5|, including tenascin 
and the heparan sulfate proteoglycans (IISPGs).
The expression of the dermal glycoprotein tenascin is 
limited in normal skin but profoundly increased in chronic 
and subacute inflammatory disorders such as psoriasis, 
acne, and alopecia areata |4, 6, 7]. ll is also found in in­
creased amounts in epidermal tumors and in wound heal­
ing 181. In acute inflammation, however, the expression of 
tenascin has never been investigated.
In addition, the basal membrane (BM) and cell surface 
associated HSPGs have been shown to be changed in pso­
riasis |5 |. HSPGs play an important role in assembly of 
the BM, bind growth factors and influence charge-depen­
dent transport of molecules. They consist of heparan sul­
fate (HS) side chains, which are covalently bound to a 
core protein, and they are present in the BM of the epi­
dermis, cell membranes and blood vessels |9|. In psoria­
sis, cell surface-associated HSPGs are absent, whereas 
they are clearly found in the epidermis of normal skin |5|.
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Furthermore, the pattern of basal membrane-associated 
HSPGs are also altered in psoriasis: the high-sulfated do­
main of the HS side chain is absent in the tips of the der­
mal papillae [5].
In this study, the expression of the ECM proteins 
tenascin and basal and cell surface-associated HSPGs was 
studied immunohistochemically in normal human skin af­
ter epicutaneous application of LTB4 over 72 h. In order to 
find out whether tenascin expression is most related to 
proliferation or differentiation in this model of acute in­
flammation, its expression in relation to epidermal prolif­
eration and influx of inflammatory cells (PMNs and T 
lymphocytes) was investigated. This study indicated that 
the application of LTB4 induced many changes in ECM 
molecules that can also be found in early psoriatic lesions.
Materials and methods
Volunteers and biopsies
A group of 16 healthy male volunteers (mean age 27 years) with­
out signs or history o f  skin disorders participated in this study. Be­
fore the application o f  LTB4, a 4-m m  punch biopsy was taken un­
der local anaesthesia, to assess the histology of the unchallenged 
skin.
Aliquots o f  100 ng LTB 4 (Paesel, Frankfurt, Germany) dis­
solved in 1 0  jUl ethanol were applied to the skin of the upper part 
of the back of the volunteers through a plastic cylinder (6,5 mm di­
ameter) and the ethanol was evaporated under a stream of nitrogen. 
The test sites were covered with impermeable dressing (Silver 
Patch, van der Bend, Brielle, The Netherlands) held in place with 
Leukosil'k tape (Beiersdorf, Hamburg, Germany),
Further 4 -m m  punch biopsies were taken 24 and 72 h after 
LTB4 application under local anaesthesia. The biopsies were washed 
in phosphate-buffered saline (PBS; NPBI, Enimer-Compascuum, 
The Netherlands), embedded in Tissue Tek OCT compound (Miles 
Scientific, Naperville, 111.), snap-frozen in liquid nitrogen and 
stored a t —80°C. They were sectioned at 7 pm  and fixed for 10 min 
in acetone/ether (60/40 voI%) for MIB-1, or in acetone (0°C) for 
staining with the other antibodies and again stored at -80°  C until 
use.
Permission to conduct this study was obtained from the local 
Ethics Committee of the University Hospital Nijmegen. Informed 
consent was given by all subjects in this study. All volunteers tol­
erated the applications of L T B 4 well. After 24 h, slight erythema 
was seen at the application sites.
Antibodies
For immunohistochemical staining o f  tenascin, the monoclonal an­
tibody (mAh) T2H5 was used (kindly provided by Dr. A. A. Ver- 
straten, The Netherlands Cancer Institute, Amsterdam, The Nether­
lands). For immunohistochemical staining of HSPGs, three mAbs 
were used: JM-72, JM-403, and JM-13 (J. vd Born, Department of 
Nephrology, University Hospital Nijmegen). The production, char­
acterization and demonstration o f  specificity of these mAbs has 
been carried out by van den Born et al. [10-13], The mAh JM -72 
is directed against the BM-associated HSPG core protein, JM-13 
against the sulfated domains o f  the HS side chains and JM-403 
against the unmodi fied/low-sulfated domains of the HS side chains. 
To study inflammation, the m A bs T I 1, directed against T  lympho­
cytes (anti-CD2; Dakopatts, Copenhagen, Denmark) and antielas- 
tase against elastase present in PM N  (Dakopatts) were used. The 
mAb MIB-1 which detects the nuclear antigen Ki-67 present in the 
late G h S and G2 + M phases o f  the cell cycle was used as a marker 
for proliferation (Im mu no tech, Marseille, France).
Im mu no h i s to ch em ic a 1 s ta i n i n g
For staining with the mAbs JM-72 (1:250 in PBS), JM-403 ( 1:250), 
T2I-I5 ( 1 :2000), M IB -l ( 1 :50) and antielastase ( 1 : 100) and indi­
rect peroxidase technique was used. After thawing at room tem­
perature for 30 min, slides were fixed again in acetone (0°C), or in 
acetone/ether (60/40 vol%) for MIB staining, for 10 min. They were 
washed in PBS and incubated for 1 h with the primary antibodies. 
After washing twice in PBS the slides were incubated for 30 min 
with a solution of peroxidase-conjugated rabbit antimouse immu­
noglobulins (RAM-Ig) l ; 50 (Dakopatts) in phosphate buffer con­
taining 5%  human AB serum, After two further washes in PBS, 
slides were stained in a solution of 3-amino-9-ethyl-carbazole (AEC) 
in sodium acetate buffer containing 0.01% H 20 2 for 1 0  min.
Staining with the m Ab JM-13 was carried out using the Vec- 
tastain Elite ABC kit (Vector Laboratories, Burlingame, Calif.). 
Sections were preincubated for 20 min with 20% normal horse 
serum and after removing the excess serum, sections were incu­
bated with an undiluted culture supernatant of the mAb JM-13 for 
60 min. After two washing steps, sections were incubated for 30 
min with a solution of horse antimouse immunoglobulins, diluted 
1 :200 in PBS containing 1 % bovine serum albumin. This was fol­
lowed by a washing step and incubation with Vectastain Elite 
ABC reagent for 30 min. After two further washes in PBS, slides 
were stained in a solution of AEC in sodium acetate buffer con­
taining 0 .0 1 % H 2O 2 for 1 0  min.
Staining with T l  1 was carried out using a peroxidase antiper­
oxidase technique (PAP). Slides were incubated with the primary 
antibody (1: 100) for 60 min, washed twice in PBS and than incu­
bated with 1; 50 RAM -Ig (Dakopatts). After two more washes in 
PBS, PAP complexes were added (Dakopatts). The incubation with 
RAM-Ig and PAP was repeated and after two additional washes in 
PBS and preincubation with sodium acetate buffer, pH 4.9, slides 
were stained with AEC solution. All slides were counterstained 
with M ayer’s hematoxylin (Sigma, St. Louis, Mo.) mounted in 
glycerine gelatine (Sigma), and studied by light microscopy.
Histological examination
The distribution of the stainings was assessed by two independent 
investigators, Tenascin expression in the dermis was assessed us­
ing an eight-point scale: 0  =  no staining, 1 = sporadic staining in 
the upper dermis adjacent to the BM of the dermoepidermal junc­
tion (DEJ), 2 = a patchy distribution In the upper dermis adjacent 
to the BM, but not present in all dermal papillae, 3 = a patchy ex­
pression in the tips o f  all dermal papillae, but not continuous, 4 =
3 but extending more deeply into the dermis, 5 = a thin but contin­
uous layer adjacent to the BM, 6  = a continuous layer adjacent to 
the BM  and in the papillary dermis, 7 = staining extending into the 
reticular dermis. Expression of HSPGs (JM-13, JM-403 and JM- 
72) in the BM  of the DEJ and the BM of blood vessels was ap­
praised using a three-point scale: 0  = staining not present, 1 = dis­
continuous staining, 2 = continuous staining. The expression of 
cell surface-associated HSPGs (JM-403 in the epidermis) was as­
sessed using a four-point scale: 0  = no staining, 1 = sporadic stain­
ing, 2 = pronounced staining, 3 = complete staining. Epidermal 
proliferation was measured by counting the number of MIB-1-pos­
itive nuclei per millimeter length of section. The density of PMN 
and T  lymphocytes was assessed in the epidermis and dermis using 
seven-point scales: epidermis  0  = no positive cells observed, 1 = 
sporadic staining, 2 = minimal presence, 3 = moderate presence,
4 = moderate/pronounced presence, 5 = pronounced presence, 6  = 
complete staining; dermis*0  =  no positive cells, 1 = sporadic stain­
ing, 2 = 1—25% of infiltrate cells stained, 3 -  26-50% , 4 = 
51-75% , 5 = 76 -99% , 6  = 100%. The dermal infiltrate was subdi­
vided into perivascular staining and diffuse dermal staining.
Statistical analysis
For statistical analysis S tudent’s Mest was used. The chosen level 
of significance was P  < 0.05.
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Results
Immunohistochemistry
#*»*»
In all specimens of unchallenged skin, tenascin 
sion was discontinuous, varying from sporadic to 
in the papillary dermis (Fig. I). Continuous staining for 
tenascin was found adjacent to the BM of blood vessels, 
eccrine sweat ducts and hair follicles. A slight decrease in 
tenascin expression was seen 24 h after LTB4 application, 
but after 72 h, a marked increase in tenascin was found 
OP = 0,089 and P  = 0.0006, respectively). All dermal 
papillae were intensely stained and the staining extended 
into the papillary and reticular dermis (Fig. 2), and in 10
was continuous.
Fig. I Tenascin expression in normal human skin (x 200)
Pig - 2  Tenascin expression in normal skin 72 h after topical LTB 4 
application (x 2 0 0 )
Fig* 3 MS PC,I slaining in normal skin using mAh JM-403 directed 
against llie low-suU'ated side chains (x 2 0 0 )
F ig .4 HSPG staining in normal skin 72 h after LTB4l application 
(JM-403, x  200)
H SPG s
In normal skin, staining with JM-403, directed against the 
low-sulfated domains of the MS side chains, showed a ke~
After 24 hratinocyte surface-associated
of L T B e x p o s u re ,  however, the staining became 
prominent (P < 0.0001) and after 72 h the expression var-
\sy
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T abic  I Results o f  i inmuno- 
histochemieal stainings (means
± SEM, /7= 16)
0  h 24 h 72 h
Tenascin 2.69 (± 0 .34 ) 2.25 (±0.30) 4.63 (±0.39)
HSPG core DEJ 2 . 0 0  ( ± 0 .0 0 ) 2 . 0 0  ( ± 0 ,0 0 ) 2 . 0 0  ( ± 0 .0 0 )
HSPG core blood vessels 2 , 0 0  ( ± 0 .0 0 ) 2 . 0 0  (± 0 .0 0 ) 2 . 0 0  ( ± 0 .0 0 )
HSPG core epidermis 0 . 0 0  ( ± 0 .0 0 ) 0 . 0 0  ( ± 0 .0 0 ) 0 . 0 0  ( ± 0 .0 0 )
HS low-sulfated DEJ 2 . 0 0  ( ± 0 .0 0 ) 2 . 0 0  (± 0 .0 0 ) 2 . 0 0  ( ± 0 .0 0 )
HS low-sulfated blood vessels 2 . 0 0  ( ± 0 .0 0 ) 2 . 0 0  (± 0 .0 0 ) 2 . 0 0  ( ± 0 .0 0 )
FIS low-sulfated epidermis 2 . 0 0  ( ± 0 .2 0 ) 0.88 (±0.13) 0.31 ( ± 0 . 1 2 )
HS highly sulfated DEJ 2 . 0 0  ( ± 0 .0 0 ) 2 . 0 0  (± 0 .0 0 ) 2 . 0 0  ( ± 0 .0 0 )
HS highly sulfatecl blood vessels 2 . 0 0  ( ± 0 .0 0 ) 2 . 0 0  (± 0 .0 0 ) 2 . 0 0  ( ± 0 .0 0 )
HS highly sulfated epidermis 0 . 0 0  ( ± 0 .0 0 ) 0 . 0 0  ( ± 0 .0 0 ) 0 . 0 0  ( ± 0 .0 0 )
Ki-67-positive nuclei 62.1 (± 3.99) 23.2 (± 3.54) 201 (±33.8)
Elastase, epidermis 0 . 0 0  ( ± 0 .0 0 ) 3.78 (±0.23) 1.63 (±0.21)
Elastase, diffuse dermis 0 . 0 0  ( ± 0 ,0 0 ) 4.00 (±0.18) 2.41 (±0.30)
Elastase, perivascular 0.13 (± 0 .0 9 ) 3.19 (±0.19) 1.94 ( ± 0 . 1 2 )
T lymphocytes, epidermis 0.97 (± 0 .1 6 ) 1.44 (±0 .18) 1.50 (±0,13)
T lymphocytes, diffuse dermis 1.06 ( ± 0 , 1 1 ) 1.69 (±0.15) 2.34 (±0.16)
T lymphocytes, perivascular 2.09 (± 0 ,0 7 ) 2 . 6 6  (± 0 .2 0 ) 3.53 (±0.26)
4). In addition, JM-403 staining was seen in the BM of the 
epidermis and blood vessels where no differences were 
seen between challenged and unchallenged skin.
Neither JM-72 (directed against the core protein of 
HSPG) nor JM-13, (directed against the highly sulfated 
domains of the HS side chains) showed differences in ex­
pression between unchallenged and challenged skin 24 
and 72 h after LTB4 application. The distribution of JM- 
72 was continuous and restricted to the BM of the DEJ 
and blood vessels. JM-13 staining of the BM of the DEJ 
was comparable to JM-72 staining but the BM of blood 
vessels did not stain before or after application of LTB4. 
Semiquantitative data on immunohistochemical stainings 
are summarized in Table I.
Correlation of tenascin expression
with epidermal proliferation and inflammation
Proliferation
The number of MIB-positive nuclei changed after LTB4 
challenge: following a reduction after 24 h (P < 0.0001), 
a marked increase was observed at 72 h (P = 0.001). Fig­
ure 5 a  shows that the changes in the expression of 
tenascin were correlated significantly with the numbers of 
-stained nuclei in the epidermis (/* = 0,642, P < 
0.0001).
i m at ion
In epidermal and dermal skin compartments a repro­
ducible accumulation of PMNs was seen as assessed by 
staining for leukocyte elastase. Maximal presence of 
PMNs was seen 24 h after LTB4 exposure (P < 0.0001) in 
the dermis in a perivascular and diffuse pattern, as well as 
in the epidermis, At 72 h there were substantially fewer
PMNs in both compartments (P < 0.0001) but they were 
still present. Only a borderline significant correlation was 
found between tenascin expression and epidermal PMNs 
(r = 0.27, P  = 0.06). No correlations were found between 
the presence of PMNs in the dermis and tenascin expres­
sion.
In contrast to the slight increase in epidermal T lym­
phocytes, dermal diffuse and perivascular T lymphocytes 
showed a marked increase in number, with a maximum at 
72 h (P < 0.0001). The expression of dermal T lympho­
cytes (perivascular and diffuse) correlated significantly 
with tenascin expression (r = 0.45, P = 0 .001 and r = 0.48, 
P  = 0.0004, respectively). This is shown in the Figures 5
b, c, No significant correlation was found between epider­
mal T lymphocytes and tenascin expression.
Discussion
In this study, the expression of the ECM molecules tenascin 
and HSPG in acutely inflamed skin after topical LTB4 ap­
plication was investigated and related to epidermal prolif­
eration and cutaneous inflammation. À significant in­
crease in tenascin expression was found as early as 72 h 
after LTB4 challenge. The staining pattern was similar to 
that found in psoriasis, The increase in tenascin correlated 
with epidermal proliferation, the presence of T lympho­
cytes in the dermis and the influx of epidermal PMN.
Tenascin is known to be increased in conditions of in­
creased epidermal proliferation including wound healing, 
tape stripping and hyperproliferative skin diseases such as 
psoriasis and skin carcinomas [4, 14, 15]. It is thought that 
the production of tenascin might be stimulated by the pro­
liferating epidermis [15]. On the other hand, an increased 
expression of tenascin has been reported in skin disorders 
characterized by inflammation (alopecia areata, acne), in 
areas where many inflammatory cells are present. It has 
been postulated that cytokines derived from inflammatory
sK
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infiltrate may regulate tenascin synthesis [6, 7|. In addi­
tion» tenascin inhibits monocyte adhesion to the ECM and 
alters the adhesion properties of T cells in vitro, which 
may be due to abrogation of an accessory cell function at 
an early stage of the interaction between antigen-present-
ing cells and T cells 116], and may therefore have antiin­
flammatory activity. Furthermore, tenascin is elevated 
during acute phase responses [17], In this model, in which 
act lie inflammation can be investigated, tenascin expres­
sion correlated best with the expression of MIB-1, a marker 
for proliferation.
A significant alteration in cell surface-associated HSPG 
expression was found in normal skin after LTB4 applica­
tion. The pattern of cell membrane-associated staining 
present in normal epidermis after staining with JM-403 
disappeared 72 h after LTB4 application. In psoriasis, this 
cell membrane-associated staining is also absent, in con­
trast to uninvolved psoriatic and normal skin, suggesting a 
comparable mechanism behind the changed JM-403 stain­
ing in psoriasis and the LTB4 skin model. An influx of in­
flammatory cells in the dermis and epidermis may influ­
ence the expression of cell membrane-associated HSPG s. 
In acute irritant dermatitis, however, an increase in the 
concentration of HS occurs in normal skin and psoriatic 
skin [18], as determined using glycosaminoglycans elec­
trophoresis of skin biopsies. Staining with JM-403 showed 
a continuous staining in the DEJ of normal skin both be­
fore and 72 h after LTB4 application.
Staining of the core protein of HSPG did not show any 
changes in acute LTB4-induced. inflammation. Previous 
studies on LTB4-challenged skin have indicated degrada­
tion of BM components by neutrophil elastase and ultra- 
structural damage of the BM [1, 19]. This does not neces­
sarily imply, that the epitope of the large core protein of 
HSPG, stained by JM-72, disappears. It can be concluded 
that the core protein of HSPG, one of the major con­
stituents of the BM, remains virtually unaffected.
Staining with JM-13, against the high-sulfated parts of 
the HSPG side chains, did not change after LTB4 applica­
tion. In psoriasis, however, loss of staining of JM-13 has 
been found in the tips of the dermal papillae |5|, where 
PMNs are moving from the tips of the dermal papillae 
into the epidermis and are known to release elastase and 
free radicals. Degradation of the DEJ by proteolytic en­
zymes from human skin and human PMNs has been de­
scribed [20 -221. Furthermore, Diamond et al. have de­
scribed a direct interaction between the leukocyte integrin 
Mac-1 and HSPGs [23|. Mac-1 is the main integrin in­
volved in adhesion of PMN. It has thus been speculated 
that in psoriasis Ihe loss of side chain staining of HSPG 
could be due to cleavage of the JM-13 epitope by prote­
olytic enzymes, in the LTB.j model however, migrating 
PMNs did not cause visible cleavage of Ihe JM-13 epitope 
during 72 h. In this study, staining of the dermal blood 
vessels was unaltered, although the loss of HSPGs has 
been previously reported in endothelial cells caused by 
PMN-derived proteases [24],
In conclusion, pronounced changes in the dermoepi- 
dermal interface were found in acute LTB.pinduced in­
flammation, An increased tenascin expression and a re­
duction in keratinoeyte-associated HSPG staining in the 
epidermis were detected. Correlations with epidermal pro­
liferation as well as cutaneous inflammation were found, 
but the correlation with proliferation of the epidermis was
ac
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infiltrate may regulate tenascin synthesis [6, 7], In addi­
tion, tenascin inhibits monocyte adhesion to the ECM and 
alters the adhesion properties of T  cells in vitro, which 
may be due to abrogation of an accessory cell function at
ing cells and T cells [16], and may therefore have antiin­
flammatory activity. Furthermore, tenascin is elevated 
during acute phase responses [17]. In this model, in which 
actue inflammation can be investigated, tenascin expres­
sion correlated best with the expression of MIB-l, a marker 
for proliferation.
A significant alteration in cell surface-associated HSPG 
expression was found in normal skin after LTBt, applica­
tion. The pattern of cell membrane-associated staining 
present in normal epidermis after staining with JM-403 
disappeared 72 h after LTB4 application. In psoriasis, this 
cell membrane-associated staining is also absent, in con­
trast to uninvolved psoriatic and normal skin, suggesting a 
comparable mechanism behind the changcd JM-403 stain­
ing in psoriasis and the LTB4 skin model. An influx of in­
flammatory cells in the dermis and epidermis may influ­
ence the expression of cell membrane-associated HSPGs, 
In acute irritant dermatitis, however, an increase in the 
concentration of HS occurs in normal skin and psoriatic 
skin 118], as determined using glycosaminoglycans elec­
trophoresis of skin biopsies. Staining with JM-403 showed 
a continuous staining in the DEJ of normal skin both be­
fore and 72 h after LTB4 application.
Staining of the core protein of HSPG did not show any 
changes in acute LTB4-induced inflammation. Previous 
studies on LTB4-ehallenged skin have indicated degrada­
tion of BM components by neutrophil elastase and ultra- 
structural damage of the BM [1, 19], This does not neces­
sarily imply, that the epitope of the large core protein of 
HSPG, stained by JM-72, disappears. It can be concluded 
that the core protein of HSPG, one of the major con­
stituents of the BM, remains virtually unaffected.
Staining with JM-13, against the high-sulfated parts of 
the HSPG side chains, did not change after LTB4 applica­
tion. In psoriasis, however, loss of staining of JM-13 has 
been found in the tips of the dermal papillae |5|, where 
PMNs are moving from the tips of the dermal papillae 
into the epidermis and are known to release elastase and 
free radicals. Degradation of the DEJ by proteolytic en­
zymes from human skin and human PMNs has been de­
scribed [20-22], Furthermore, Diamond et al. have de­
scribed a direct interaction between the leukocyte integrin 
Mac-1 and HSPGs |23|. Mac-1 is the main integrin in­
volved in adhesion of PMN. It has thus been speculated 
that in psoriasis the loss of side chain staining of HSPG 
could be due to cleavage of the JM-13 epilope by prote­
olytic enzymes. In the LTB.j model however, migrating 
PMNs did nol cause visible cleavage of the JM-13 epitope 
during 72 h. In this study, staining of the dermal blood 
vessels was unaltered, although the loss of HSPGs has 
been previously reported in endothelial cells caused by 
PMN-derived proteases 124].
In conclusion, pronounced changes in the dermocpi- 
dermal interface were found in acute LTB,(-induced in­
flammation, An increased tenascin expression and a re­
duction in keratinocyte-associated HSPG staining in the 
epidermis were detected. Correlations with epidermal pro­
liferation as well as cutaneous inflammation were found,
an early stage of the interaction between antigen-present- but the correlation with proliferation of the epidermis was
336
most pronounced. The findings indicate that the model of 
LTB4-induced acute cutaneous inflammation displays 
many characteristics of the early psoriatic lesion and 
could serve as a model for the study of some of the cell bi­
ological changes in this disease.
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